NASA cleanroom fungus could survive a trip to Mars, raising contamination concerns

A fungus pulled from NASA cleanrooms kept surviving tests that were meant to mimic nearly every stage of a trip to Mars. That ...
European Medical Journal

AZ’s Andrew Menzies-Gow on a new era for respiratory care

At AstraZeneca, Andrew Menzies-Gow leads global medical strategy across two fast-moving therapy areas, focusing here on ...
Hosted on MSN

Making sense of chronic disease care and coding

Managing chronic disease effectively requires more than treatment — it depends on precise coding, timely screenings, and preventive strategies working together to protect patient health. Updated ...

CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China

China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that the New Drug Application (NDA) in China (SAR) indication of MG-K10 (generic name: Comekibart Injection, “MG-K10 ...
ThaiPR.NET

IEAT and AstraZeneca Proactively Conduct Lung Screenings, Visiting GC and SCG Plants for AI-Assisted X-Rays to Drive Early Detection

The Industrial Estate Authority of Thailand (IEAT) and AstraZeneca (Thailand) Co., Ltd. are moving forward with the Health ...

The new era of life sciences

Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...
Open Heart

Sex differences in the diagnosis, management and outcomes of patients with infective endocarditis

Background Despite growing interest in male–female differences in cardiovascular disease, evidence in infective endocarditis ...
Business & Finance

Top 100 Companies Leading in Wellbeing 2026｜Business & Finance in partnership with Ibec – Part 4

Part of the St. Vincent’s Healthcare Group, SVUH employs over 4,000 people and is home to national programmes including the ...
MPR

Tozorakimab Reduces COPD Exacerbations in Phase 3 MIRANDA Trial

Tozorakimab is an investigational monoclonal antibody designed to bind and inhibit interleukin-33 (IL-33), an alarmin cytokine. This targeted approach is expected to reduce airway inflammation and ...
pharmaphorum

Where others missed, AZ's IL-33 drug hits the mark in COPD

AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...

Astra posts another late-stage trial win for COPD therapy

AstraZeneca (AZN) stock is in focus as tozorakimab marks a new Phase 3 trial win in chronic obstructive pulmonary disease, a ...
The New England Journal of Medicine

Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation

Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...